Hiroe Sato

1.1k total citations
61 papers, 774 citations indexed

About

Hiroe Sato is a scholar working on Rheumatology, Molecular Biology and Nephrology. According to data from OpenAlex, Hiroe Sato has authored 61 papers receiving a total of 774 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Rheumatology, 20 papers in Molecular Biology and 16 papers in Nephrology. Recurrent topics in Hiroe Sato's work include Systemic Lupus Erythematosus Research (16 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (16 papers) and Renal Diseases and Glomerulopathies (12 papers). Hiroe Sato is often cited by papers focused on Systemic Lupus Erythematosus Research (16 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (16 papers) and Renal Diseases and Glomerulopathies (12 papers). Hiroe Sato collaborates with scholars based in Japan, Australia and United States. Hiroe Sato's co-authors include Takeshi Kuroda, Ichiei Narita, Masaaki Nakano, Yoko Wada, Takeshi Nakatsue, Fumitake Gejyo, Naohito Tanabe, Daisuke Kobayashi, Junichiro James Kazama and Satoshi Ito and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Scientific Reports.

In The Last Decade

Hiroe Sato

59 papers receiving 759 citations

Peers

Hiroe Sato
Nina Boulman Israel
Lachy McLean United States
Lindi Jiang China
Javier del Pino‐Montes Spain
A Ryckewaert France
Anita Persson Sweden
Ying‐Chou Chen Taiwan
Chanyuan Wu China
Mario Jiménez-Hernández Spain
Şenol Kobak Türkiye
Nina Boulman Israel
Hiroe Sato
Citations per year, relative to Hiroe Sato Hiroe Sato (= 1×) peers Nina Boulman

Countries citing papers authored by Hiroe Sato

Since Specialization
Citations

This map shows the geographic impact of Hiroe Sato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroe Sato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroe Sato more than expected).

Fields of papers citing papers by Hiroe Sato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroe Sato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroe Sato. The network helps show where Hiroe Sato may publish in the future.

Co-authorship network of co-authors of Hiroe Sato

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroe Sato. A scholar is included among the top collaborators of Hiroe Sato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroe Sato. Hiroe Sato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaneko, Yoshikatsu, Hiroe Sato, Daisuke Kobayashi, et al.. (2023). Pathogenetic associations of anti-ribosomal P protein antibody titres and their subclasses in patients with systemic lupus erythematosus. Lara D. Veeken. 63(5). 1411–1421. 4 indexed citations
2.
Sato, Hiroe, Naoki Kondo, Daisuke Kobayashi, et al.. (2021). Lower trabecular bone score is associated with an increased incidence of localized femoral periosteal thickening. Journal of Bone and Mineral Metabolism. 39(6). 952–961. 1 indexed citations
3.
Sato, Hiroe, Chinatsu Takai, Junichiro James Kazama, et al.. (2020). Serum hepcidin level, iron metabolism and osteoporosis in patients with rheumatoid arthritis. Scientific Reports. 10(1). 9882–9882. 29 indexed citations
4.
Sato, Hiroe, Chinatsu Takai, Naoki Kondo, et al.. (2020). Cumulative incidence of femoral localized periosteal thickening (beaking) preceding atypical femoral fractures in patients with rheumatoid arthritis. Osteoporosis International. 32(2). 363–375. 6 indexed citations
5.
Sato, Hiroe, Naoki Kondo, Daisuke Kobayashi, et al.. (2019). High bisphosphonate treatment rates and the prevalence of atypical femoral fractures in patients with systematic lupus erythematosus: a single-center retrospective study performed in Japan. Rheumatology International. 39(10). 1803–1810. 7 indexed citations
6.
Kuroda, Takeshi, Naohito Tanabe, Hiroe Sato, et al.. (2018). Association between Elevated Mean Corpuscular Volume and C-reactive protein in Patients with Rheumatoid Arthritis. 1(5). 1 indexed citations
7.
8.
Sato, Hiroe, Naoki Kondo, Takeshi Nakatsue, et al.. (2015). The cumulative incidence of and risk factors for latent beaking in patients with autoimmune diseases taking long-term glucocorticoids and bisphosphonates. Osteoporosis International. 27(3). 1217–1225. 17 indexed citations
9.
Sato, Hiroe, Daisuke Kobayashi, Asami Abe, et al.. (2014). Tocilizumab treatment safety in rheumatoid arthritis in a patient with multiple sclerosis: a case report. BMC Research Notes. 7(1). 641–641. 23 indexed citations
10.
Kuroda, Takeshi, Hiroe Sato, Takeshi Nakatsue, et al.. (2014). Effects of a biologic agent in a patient with rheumatoid arthritis after treatment for methotrexate-associated B-cell lymphoma: a case report. BMC Research Notes. 7(1). 229–229. 5 indexed citations
11.
Kuroda, Takeshi, Naohito Tanabe, Hiroe Sato, et al.. (2013). Distribution of amyloid deposits in the kidneys of a patient with reactive amyloidosis associated with rheumatoid arthritis. BMC Research Notes. 6(1). 231–231. 2 indexed citations
12.
Iguchi, Akira, Yoko Wada, Daisuke Kobayashi, et al.. (2012). A case of MPO- and PR3-ANCA-positive hypertrophic cranial pachymeningitis with elevated serum IgG4. Modern Rheumatology. 23(1). 151–155. 16 indexed citations
13.
Kuroda, Takeshi, Naohito Tanabe, Daisuke Kobayashi, et al.. (2012). Treatment with Biologic Agents Improves the Prognosis of Patients with Rheumatoid Arthritis and Amyloidosis. The Journal of Rheumatology. 39(7). 1348–1354. 22 indexed citations
14.
Sato, Hiroe, Naohito Tanabe, Akira Murasawa, et al.. (2012). Procalcitonin Is a Specific Marker for Detecting Bacterial Infection in Patients with Rheumatoid Arthritis. The Journal of Rheumatology. 39(8). 1517–1523. 27 indexed citations
15.
Kuroda, Takeshi, Naohito Tanabe, Daisuke Kobayashi, et al.. (2010). Programmed initiation of hemodialysis for systemic amyloidosis patients associated with rheumatoid arthritis. Rheumatology International. 31(9). 1177–1182. 4 indexed citations
16.
Kuroda, Takeshi, Daisuke Kobayashi, Hiroe Sato, et al.. (2010). Mizoribine therapy in a patient with lupus nephritis: the association between mizoribine concentration and peritoneal dialysis. Modern Rheumatology. 20(3). 296–300. 3 indexed citations
17.
Sato, Hiroe, Toshiaki Sugaya, Hiroshi Otani, et al.. (2009). Tocilizumab dramatically ameliorated life-threatening diarrhea due to secondary amyloidosis associated with rheumatoid arthritis. Clinical Rheumatology. 28(9). 1113–1116. 40 indexed citations
18.
Sato, Hiroe, Junichiro James Kazama, Takeshi Kuroda, et al.. (2008). Serum cystatin C measured by a sol particle homogeneous immunoassay can accurately detect early impairment of renal function. Clinical and Experimental Nephrology. 12(4). 270–276. 5 indexed citations
19.
Sato, Hiroe, Takashi Miida, Yoko Wada, et al.. (2007). Atherosclerosis is accelerated in patients with long-term well-controlled Systemic Lupus Erythematosus (SLE). Clinica Chimica Acta. 385(1-2). 35–42. 37 indexed citations
20.
Kuroda, Takeshi, Mitsuhiro Ueno, Hiroe Sato, et al.. (2006). A case of Takayasu arteritis complicated with glomerulonephropathy mimicking membranoproliferative glomerulonephritis: a case report and review of the literature. Rheumatology International. 27(1). 103–107. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nina Boulman Breakdown of academic impact, for papers by Lachy McLean Breakdown of academic impact, for papers by Lindi Jiang Breakdown of academic impact, for papers by Javier del Pino‐Montes Breakdown of academic impact, for papers by A Ryckewaert Breakdown of academic impact, for papers by Anita Persson Breakdown of academic impact, for papers by Ying‐Chou Chen Breakdown of academic impact, for papers by Chanyuan Wu Breakdown of academic impact, for papers by Mario Jiménez-Hernández Breakdown of academic impact, for papers by Şenol Kobak
Rankless by CCL
2026